Information
-
Trademark
-
97815166
-
International Classifications
-
Filing Date
February 28, 2023
a year ago
-
Transaction Date
December 27, 2024
9 days ago
-
Status Date
December 27, 2024
9 days ago
-
Location Date
December 27, 2024
9 days ago
-
First Use Anywhere Date
May 17, 2018
6 years ago
-
First Use In Commerce Date
May 17, 2018
6 years ago
-
Status Code
654
-
Current Location
TMO LAW OFFICE 115
Employee Name
LEVINE, HOWARD
-
Attorney Docket Number
VERAC.055T
Attorney Name
Rosaleen H. Chou
Law Office Assigned Location Code
M60
-
Owners
Mark Drawing Code
4
Mark Identification
ENVISIA
Case File Statements
- GS0051: Kits for in vitro diagnostic testing for pulmonary diseases and conditions; Reagents for medical use; Molecular diagnostic assays for testing of bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Medical preparations used to diagnose bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Diagnostic agents, preparations and substances for medical purposes; Diagnostic test kits consisting primarily of reagents for use in testing bodily fluids, tissue, cells, blood, disease, cancer, genetics, and pathogens; Medical diagnostic test kits consisting primarily of reagents for detecting pathogens; Clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing genetic material; Clinical, genetic and specialized medical diagnostic test kits comprised primarily of collection tubes, buffers, tube holders, transport bags, shipping containers, and instruction sheets for use in scientific and clinical diagnostic equipment used to detect disease, cancer, genetics, and pathogens; Chemicals, assays, reagents and kits consisting primarily of chemicals, assays, and reagents for medical testing and diagnostic purposes in the fields of genomics, diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic reagents, and kits comprised of medical diagnostic reagents, collection tubes, buffers, tube holders, transport bags, and instruction sheets, for diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Medical diagnostic testing kits comprised primarily of reagents and assays for use in diagnostics and diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use
- GS0011: Reagents for scientific or research use; Diagnostic kits and test kits primarily composed of reagents for determination of genomic and transcriptomic information for scientific or research purposes; Testing kits comprised primarily of preparations, reagents, test strips, collection tubes, buffers, tube holders, transport bags and assays for use in scientific or research in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical and veterinary use; Kits comprised primarily of biological reagents and comprised secondarily of a protocol in the form of printed instructions for use thereof for scientific and research purposes; Tests designed to isolate and extract cells for genetic analysis comprised of reagents for scientific or research purposes; Reagents and molecule or cell markers for scientific or research purposes
Case File Event Statements
-
3/3/2023 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
3/19/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
11/29/2023 - a year ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/22/2024 - 10 months ago
7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Type: XELR
-
11/29/2023 - a year ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/29/2023 - a year ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/29/2023 - a year ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/22/2024 - 10 months ago
8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Type: XELG
-
5/29/2024 - 7 months ago
10 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/29/2024 - 7 months ago
11 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/29/2024 - 7 months ago
9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/28/2024 - 6 months ago
13 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
6/28/2024 - 6 months ago
14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
6/28/2024 - 6 months ago
12 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
12/27/2024 - 9 days ago
15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC